FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891471230> ?p ?o ?g. }

• W2891471230 endingPage "1007" @default.
• W2891471230 startingPage "1002" @default.
• W2891471230 abstract "To study the inhibitory effect of 10-gingerol on the proliferation of hepatocellular carcinoma HepG2 cells and the role of Src/STAT3 signaling pathway in mediating the effect.SYBYL-X2.1 software was used to simulate the interaction between 10-gingerol and Src. HepG2 cells treated with 10-gingerol at 1, 3, 10 or μol/L for 24 h were assessed for cell viability using MTT assay, and EdU staining was used to detect the cell proliferation and calculate the number of positive cells. The expressions of p-Src and p-STAT3 were detected using Western blotting, and the mRNA expressions of the target genes of STAT3 (cyclin D1 and CMCC) were detected using qPCR.10-gingerol was capable of forming hydrogen bond with such Src residues as TRY-340, MET-341, MET-314, ASP-404, and ILE-336. MTT assay showed that 10-gingerol at 3 and 10 μmol/L significantly lowered the viability of HepG2 cells (P < 0.001). Treatment with 1, 3, and 10 μmol/L 10-gingerol significantly reduces the number of EdU-positive HepG 2 cells (P < 0.001). Western blotting showed that 10-gingerol at 3 and 10 μmol/L significantly decreased the phosphorylation levels of Src and STAT3 in HepG2 cells (P < 0.01). 10-gingerol at 1, 3, and 10 μmol/L significantly decreased the mRNA expressions of cyclin D1 and CMCC as shown by qPCR (P < 0.01).10-gingerol can dose-dependently inhibit the proliferation of HepG2 cells and suppress the activation of Src and STAT3." @default.
• W2891471230 created "2018-09-27" @default.
• W2891471230 creator A5035038960 @default.
• W2891471230 creator A5051473707 @default.
• W2891471230 creator A5069907810 @default.
• W2891471230 creator A5070987601 @default.
• W2891471230 creator A5078662119 @default.
• W2891471230 date "2018-07-30" @default.
• W2891471230 modified "2023-09-23" @default.
• W2891471230 title "[10-gingerol inhibits proliferation of hepatocellular carcinoma HepG2 cells via Src/STAT3 signaling pathway]." @default.
• W2891471230 cites W1971342909 @default.
• W2891471230 cites W1999074825 @default.
• W2891471230 cites W2029286778 @default.
• W2891471230 cites W2043758117 @default.
• W2891471230 cites W2052656103 @default.
• W2891471230 cites W2052874224 @default.
• W2891471230 cites W2113231588 @default.
• W2891471230 cites W2116182014 @default.
• W2891471230 cites W2124926575 @default.
• W2891471230 cites W2125899548 @default.
• W2891471230 cites W2133054046 @default.
• W2891471230 cites W2169999050 @default.
• W2891471230 cites W2170981277 @default.
• W2891471230 cites W2301698595 @default.
• W2891471230 cites W2332492059 @default.
• W2891471230 cites W2571718349 @default.
• W2891471230 cites W2579944574 @default.
• W2891471230 cites W2590573757 @default.
• W2891471230 cites W2594056631 @default.
• W2891471230 cites W2596314029 @default.
• W2891471230 cites W2742734698 @default.
• W2891471230 cites W2752067270 @default.
• W2891471230 cites W2774837233 @default.
• W2891471230 cites W2789100532 @default.
• W2891471230 cites W2791638365 @default.
• W2891471230 cites W2792054549 @default.
• W2891471230 cites W2793470869 @default.
• W2891471230 cites W2796303943 @default.
• W2891471230 cites W2796643628 @default.
• W2891471230 cites W2799333734 @default.
• W2891471230 cites W2802665478 @default.
• W2891471230 cites W2917837889 @default.
• W2891471230 cites W2993263003 @default.
• W2891471230 doi "https://doi.org/10.3969/j.issn.1673-4254.2018.08.17" @default.
• W2891471230 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6744037" @default.
• W2891471230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30187878" @default.
• W2891471230 hasPublicationYear "2018" @default.
• W2891471230 type Work @default.
• W2891471230 sameAs 2891471230 @default.
• W2891471230 citedByCount "1" @default.
• W2891471230 countsByYear W28914712302022 @default.
• W2891471230 crossrefType "journal-article" @default.
• W2891471230 hasAuthorship W2891471230A5035038960 @default.
• W2891471230 hasAuthorship W2891471230A5051473707 @default.
• W2891471230 hasAuthorship W2891471230A5069907810 @default.
• W2891471230 hasAuthorship W2891471230A5070987601 @default.
• W2891471230 hasAuthorship W2891471230A5078662119 @default.
• W2891471230 hasConcept C104317684 @default.
• W2891471230 hasConcept C108636557 @default.
• W2891471230 hasConcept C11960822 @default.
• W2891471230 hasConcept C120504264 @default.
• W2891471230 hasConcept C1491633281 @default.
• W2891471230 hasConcept C153911025 @default.
• W2891471230 hasConcept C185592680 @default.
• W2891471230 hasConcept C199835354 @default.
• W2891471230 hasConcept C2778437423 @default.
• W2891471230 hasConcept C2778923194 @default.
• W2891471230 hasConcept C2780783641 @default.
• W2891471230 hasConcept C29537977 @default.
• W2891471230 hasConcept C502942594 @default.
• W2891471230 hasConcept C53227056 @default.
• W2891471230 hasConcept C55493867 @default.
• W2891471230 hasConcept C62112901 @default.
• W2891471230 hasConcept C62478195 @default.
• W2891471230 hasConcept C85265743 @default.
• W2891471230 hasConcept C86803240 @default.
• W2891471230 hasConceptScore W2891471230C104317684 @default.
• W2891471230 hasConceptScore W2891471230C108636557 @default.
• W2891471230 hasConceptScore W2891471230C11960822 @default.
• W2891471230 hasConceptScore W2891471230C120504264 @default.
• W2891471230 hasConceptScore W2891471230C1491633281 @default.
• W2891471230 hasConceptScore W2891471230C153911025 @default.
• W2891471230 hasConceptScore W2891471230C185592680 @default.
• W2891471230 hasConceptScore W2891471230C199835354 @default.
• W2891471230 hasConceptScore W2891471230C2778437423 @default.
• W2891471230 hasConceptScore W2891471230C2778923194 @default.
• W2891471230 hasConceptScore W2891471230C2780783641 @default.
• W2891471230 hasConceptScore W2891471230C29537977 @default.
• W2891471230 hasConceptScore W2891471230C502942594 @default.
• W2891471230 hasConceptScore W2891471230C53227056 @default.
• W2891471230 hasConceptScore W2891471230C55493867 @default.
• W2891471230 hasConceptScore W2891471230C62112901 @default.
• W2891471230 hasConceptScore W2891471230C62478195 @default.
• W2891471230 hasConceptScore W2891471230C85265743 @default.
• W2891471230 hasConceptScore W2891471230C86803240 @default.
• W2891471230 hasIssue "8" @default.
• W2891471230 hasLocation W28914712301 @default.
• W2891471230 hasOpenAccess W2891471230 @default.

• next